Pharmacy

Four drugs or medical devices approved by the FDA since May 31:

The U.S. Department of Labor is accusing an Ohio pharmacy of improperly firing one of its techs after concerns were raised about safety lapses, according to a WHIO TV news report.

CVS Caremark will pay $15.3 million to settle a lawsuit accusing the pharmacy benefit manager of denying overtime pay to employees in its call centers nationwide, according to a KCUR news report.

Eli Lilly secured federal approval for Emgality, the first migraine treatment approved in the U.S. for decreasing the frequency of episodic cluster headache attacks, the FDA announced June 4.

Insys Therapeutics has agreed to pay $225 million to settle allegations of illegally marketing an addictive fentanyl painkiller to physicians, the U.S. Justice Department announced June 5.

Drugmaker Mallinckrodt has reached a tentative deal with the U.S. Justice Department to resolve a drug bribery case, the manufacturer announced June 5. Mallinckrodt expects to pay out $15.4 million.

Below are nine legal actions involving members of the drug supply chain, including pharmaceutical manufacturers, pharmacy benefit managers, pharmacies, pharmacists and distributors, reported by Becker's Hospital Review in the last two weeks.

Bristol-Myers Squibb has unveiled the team that will lead its research and development group after its $74 billion acquisition of Celgene is finalized.

Mylan is expecting shortages of its EpiPen auto-injector to continue, according to an update on the FDA product shortages list.

CVS Health will close some unprofitable stores, according to CNBC.